JW

Jon M. Wigginton

BS Bristol-Myers Squibb: 16 patents #314 of 3,969Top 8%
IP Innate Pharma: 2 patents #42 of 85Top 50%
MA Macrogenics: 2 patents #44 of 63Top 70%
📍 Collegeville, PA: #47 of 630 inventorsTop 8%
🗺 Pennsylvania: #3,862 of 74,527 inventorsTop 6%
Overall (All Time): #253,872 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
11174315 Combination therapy for the treatment of cancer James Vasselli, Ezio Bonvini, Scott Koenig 2021-11-16
11078279 Combination therapy for the treatment of cancer Naimish Bharat Pandya, Robert Joseph Lechleider, Scott Koenig, Ezio Bonvini 2021-08-03
10688180 Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer Robert Graziano, Ashok K. Gupta, Su Young Kim, Pascale Andre 2020-06-23
10604575 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2020-03-31
10584170 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2020-03-10
10577423 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2020-03-03
10323093 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-06-18
10323092 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-06-18
10316091 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-06-11
10316090 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-06-11
10308714 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-06-04
10266595 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-04-23
10266594 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-04-23
10266596 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2019-04-23
10138299 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2018-11-27
10072082 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2018-09-11
9856320 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang 2018-01-02
9789182 Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer Robert Graziano, Ashok K. Gupta, Su Young Kim, Pascale Andre 2017-10-17